Provectus Biopharmaceuticals Announces Acceptance of PV-10® Immunotherapy Abstract for Metastatic Uveal Melanoma at American Society of Clinical Oncology (ASCO) 2022 Annual Meeting
27 avr. 2022 10h00 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, April 27, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that data from an ongoing clinical trial of investigational cancer immunotherapy PV-10, a formulation of...
Liver Cancer Diagnostics Market Worth $15.95Bn, Globally, by 2028 at 8% CAGR - Exclusive Report by The Insight Partners
07 avr. 2022 10h50 HE
|
The Insight Partners
New York, April 07, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Liver Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type...
Global Interventional Oncology Market Expected to Generate a Revenue of $3,313.5 Million, Rising at a CAGR of 6.7% during the Analysis Timeframe from 2021 to 2028 [170-Pages] | Exclusively Available by Research Dive
23 mars 2022 09h01 HE
|
Research Dive
New York, USA, March 23, 2022 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global interventional oncology market is envisioned to generate a revenue of $3,313.5...
Persbericht Biocartis Group NV: Biocartis en Ophiomics gaan samenwerken op test voor leverkanker
08 févr. 2022 01h00 HE
|
Biocartis NV
PERSBERICHT: 8 februari 2022, 07:00 CET Biocartis en Ophiomics gaan samenwerken op test voor leverkanker Primaire leverkanker1 is de zesde meest voorkomende en derde meest dodelijke vorm van kanker...
Press release Biocartis Group NV: Biocartis and Ophiomics to Collaborate on Liver Cancer Test
08 févr. 2022 01h00 HE
|
Biocartis NV
PRESS RELEASE: 8 February 2022, 07:00 CET Biocartis and Ophiomics to Collaborate on Liver Cancer Test Primary liver cancer1 is the sixth most common and third most lethal cancer in the...
Global Interventional Oncology Devices Market, 2021-2030: Opportunities in the Emergence of Local Companies in Asia-Pacific and the Middle East and Africa
06 déc. 2021 06h43 HE
|
Research and Markets
Dublin, Dec. 06, 2021 (GLOBE NEWSWIRE) -- The "Interventional Oncology Devices Market Analysis and Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's offering. The global...
Global Liver Institute Applauds Congresswoman Velázquez and Senator Duckworth for Bold Action on Liver Cancer
22 oct. 2021 10h12 HE
|
Global Liver Institute
Washington, DC, USA, Oct. 22, 2021 (GLOBE NEWSWIRE) -- (Washington, DC, Friday, October 22, 2021)—Global Liver Institute (GLI) CEO and President, Donna R. Cryer, JD, yesterday applauded the actions...
Provectus Biopharmaceuticals Provides Update on Research into Oral Administration of PV-10® Immunotherapy for Treatments of Hematology, Oncology, and Virology
04 oct. 2021 09h00 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today provided an update on the Company’s research into the systemic administration of Provectus’ investigational...
Adaptimmune Updates Data from its Phase 1 Trial for Liver Cancer at ILCA Showing Clinical Benefit
05 sept. 2021 06h15 HE
|
Adaptimmune Therapeutics plc
- One complete response, and a disease control rate of 64% with stable disease for ≥16 weeks in two patients, as of the data cutoff - - Data presented today at the International Liver Cancer...
Global $196.96 Bn Oncology Devices Market to 2025 & 2030: Major Players are Eckert & Ziegler BEBIG, Oncura, GE, Medtronic, Varian Medical Systems, Elekta, Theragenics, Accuray, and Roche Diagnostics
20 août 2021 06h08 HE
|
Research and Markets
Dublin, Aug. 20, 2021 (GLOBE NEWSWIRE) -- The "Oncology Devices Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. The global...